Incomplete harms reporting in systematic reviews of direct oral factor Xa inhibitors.

Rea J, Lee C, Kee M, Rucker B, Flores H, Walters C, Haney T, Tomlin A, Khan A, Vassar M

Open source

DOI
10.1182/bloodadvances.2025017363
Published
2025 Oct 28
Container
Blood advances
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1182/bloodadvances.2025017363,
  title = {Incomplete harms reporting in systematic reviews of direct oral factor Xa inhibitors.},
  author = {Rea J and Lee C and Kee M and Rucker B and Flores H and Walters C and Haney T and Tomlin A and Khan A and Vassar M},
  year = {2025},
  journal = {Blood advances},
  doi = {10.1182/bloodadvances.2025017363},
  url = {https://doi.org/10.1182/bloodadvances.2025017363}
}

RIS

TY  - JOUR
TI  - Incomplete harms reporting in systematic reviews of direct oral factor Xa inhibitors.
AU  - Rea J
AU  - Lee C
AU  - Kee M
AU  - Rucker B
AU  - Flores H
AU  - Walters C
AU  - Haney T
AU  - Tomlin A
AU  - Khan A
AU  - Vassar M
PY  - 2025
JO  - Blood advances
DO  - 10.1182/bloodadvances.2025017363
UR  - https://doi.org/10.1182/bloodadvances.2025017363
ER  - 

APA

J, R., C, L., M, K., B, R., H, F., C, W., T, H., A, T., A, K., & M, V. (2025). Incomplete harms reporting in systematic reviews of direct oral factor Xa inhibitors.. Blood advances. https://doi.org/10.1182/bloodadvances.2025017363

Source records